Onabotulinumtoxin A Injections for Patients With Pelvic Floor Dysfunction.

Journal of minimally invasive gynecology 2026 Vol.33(3) p. 257

Whitmore GT, Tam J, Orlando MS

관련 도메인

Abstract

[STUDY OBJECTIVE] To review the current literature surrounding onabotulinum toxin A injections for patients with pelvic floor dysfunction and to show how to perform these injections.

[SETTING] Academic tertiary care hospital DESIGN: It is estimated that about 50% to 90% of patients with chronic pelvic pain have pain that originates from myofascial sources, including the pelvic floor muscles. In patients with pelvic floor dysfunction, management consists of pelvic floor physical therapy with the addition of pelvic floor trigger point injections with a local anesthetic as needed. We offer onabotulinum toxin A to individuals who require long-term repeat trigger point injections, have barriers to accessing monthly injections, or show no durable improvement.

[INTERVENTION] We show a comprehensive pelvic floor exam and techniques for administering of onabotulinum toxin A to pelvic floor muscles in individuals with pelvic floor dysfunction, as well as a demonstration on a live patient. We perform an exam while the patient is awake, either in the clinic or at the time of the procedure, and examine the pubococcygeus, iliococcygeus, and obturator internus muscles to assess for hypertonicity and tenderness to palpation. Once sedation is initiated, 200 units of onabotulinum toxin A are then reconstituted with 20 mL of normal saline. The pudendal nerve kit allows for 1 cm depth of penetration with the needle. Approximately 1 to 2 mL of onabotulinumtoxin A are injected sequentially in multiple locations along the above-mentioned pelvic floor muscles. Medication effects may last up to 3 to 6 months, with a reduction in pain scores starting at 6 weeks and lasting through 12 weeks based on published literature. Adverse effects may include constipation, urinary incontinence, urinary tract infections, fecal incontinence, or urinary retention.

[CONCLUSIONS] Onabotulinumtoxin A may be helpful in patients with refractory pelvic floor dysfunction. We show how to perform these injections with a safe and reproducible technique.

[VIDEO ABSTRACT] Video: Onabotulinumtoxin A may be helpful in patients with refractory pelvic floor dysfunction, and we demonstrate how to perform these injections safely.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 onabotulinumtoxin 보툴리눔독소 주사 dict 4
해부 Pelvic Floor scispacy 1
해부 pubococcygeus scispacy 1
해부 iliococcygeus scispacy 1
해부 obturator internus muscles scispacy 1
해부 urinary tract scispacy 1
합병증 pelvic floor scispacy 1
약물 Onabotulinumtoxin A C2719767
onabotulinumtoxinA
scispacy 1
약물 [STUDY OBJECTIVE] scispacy 1
약물 saline scispacy 1
약물 urinary scispacy 1
약물 [CONCLUSIONS] Onabotulinumtoxin A scispacy 1
질환 constipation C0009806
Constipation
scispacy 1
질환 urinary incontinence C0042024
Urinary Incontinence
scispacy 1
질환 urinary tract infections C0042029
Urinary tract infection
scispacy 1
질환 fecal incontinence C0015732
Fecal Incontinence
scispacy 1
질환 Pelvic Floor Dysfunction C4041537
Pelvic floor dysfunction
scispacy 1
질환 chronic pelvic pain C0404484
Chronic pelvic pain of female
scispacy 1
질환 pain C0030193
Pain
scispacy 1
질환 tenderness C0234233
Sore to touch
scispacy 1
기타 Patients scispacy 1
기타 pelvic floor scispacy 1
기타 onabotulinum toxin A scispacy 1
기타 patient scispacy 1
기타 pudendal nerve kit scispacy 1

MeSH Terms

Humans; Botulinum Toxins, Type A; Female; Pelvic Floor Disorders; Neuromuscular Agents; Injections, Intramuscular; Pelvic Pain; Pelvic Floor

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문